Takeaway

• Early treatment with the antidepressant fluvoxamine prevents hospitalization of high-risk symptomatic adults with COVID-19 in the TOGETHER randomized, platform clinical trial.

Why this matters

• This study confirms a smaller randomized controlled trial.
• Fluvoxamine is an inexpensive treatment that will be highly useful in developing countries.

Study design

• Placebo-controlled, randomized,...